secwatch.observer — SEC 8-K summary
======================================

Issuer:     Liquidia Corp (LQDA)
CIK:        0001819576
Form:       8-K
Filed at:   2023-06-08T23:59:59+00:00
Accession:  0001104659-23-069414
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Liquidia enters 5-year supply deal with Plastiape for YUTREPIA inhalers
-----------------------------------------------------------------------

- Supply Agreement with Plastiape SpA for dry powder inhalers used for YUTREPIA (investigational treprostinil).
- Initial term of 5 years; no minimum purchase commitment; Company provides non-binding 12-month forecast annually.
- Customary termination provisions: material breach, insolvency, price disagreement; additional rights for change of control or repeated delivery failures.
- Agreement effective June 7, 2023; will be filed with next 10-Q.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1819576/000110465923069414/0001104659-23-069414-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1819576/000110465923069414/tm2318238d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-069414

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer